Key result
Hemodialysis in CKD is linked to ~16% higher prevalence of abnormal echo findings versus non-hemodialysis.
Why the study?
Cardiovascular disease is the leading cause of mortality in chronic kidney disease, prompting the need to evaluate echocardiographic cardiovascular changes in patients on hemodialysis versus non-hemodialysis.
Are there differences in echocardiographic cardiovascular changes between chronic kidney disease patients on hemodialysis versus those not on hemodialysis?
Cross-Sectional (n=124)
No
Are there differences in echocardiographic cardiovascular changes between chronic kidney disease patients on hemodialysis versus those not on hemodialysis?
Absolute Event Rate: 81.2% vs 70%
Chronic kidney disease patients on hemodialysis have a higher prevalence of abnormal echocardiographic findings, including left ventricular hypertrophy and valvular disease, compared to those not on hemodialysis.
No takes yet. Share an insight, caveat, or question.
Should not yet alter echo screening in dialysis patients; leaves open prognostic value pending longitudinal studies.
Kamal et al. (2026) conducted a cross-sectional in Chronic kidney disease (n=124). Hemodialysis vs. Non-hemodialysis was evaluated on Abnormal echocardiographic findings. Abnormal echocardiographic findings were more prevalent in chronic kidney disease patients on hemodialysis compared to those not on hemodialysis (81.2% vs 70.0%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: